Search clinical trials for: Luveltamab tazevibulin

Total 3 results

Sutro Biopharma, Inc.
Children's Oncology Group; Innovative Therapies For Children with Cancer Consortium

Terminated

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Acute Myeloid Leukemia (AML)

United States, Spain, Canada, France, Germany, Austria, Italy, Denmark, Netherlands
Sutro Biopharma, Inc.

Withdrawn

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Lung Cancer, Nonsmall Cell | Lung Cancer Non-small Cell Stage IV | Lung Cancer Non-Small Cell Stage IIIB

United States
Sutro Biopharma, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaborators

Terminated

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer

Israel, United States, Australia, Singapore, South Korea, Canada, New Zealand

Subscribe